NanoRepro AG Logo

NanoRepro AG

ISIN

DE0006577109

Ticker

NN6

Sector

Health Care

Sub-Industry

Health Care Supplies

Country

Germany

Year Founded

2006

About NanoRepro AG

Company Description

NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention.

The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years.

NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.

Served Area

Worldwide

Headquarters

Untergasse 8
35037, Marburg
Germany

Filings & Publications

  • Consolidated Report 2021 - Q4 German 🇩🇪
  • Consolidated Report 2022 - Q2 German 🇩🇪

Insider Trades

Date Trading entity / Person Association Trade type Volume
04.08.2023 Jüngst, Lisa Board Buy EUR 45,880.06
02.08.2023 Stiller, Dr. Olaf Supervisory board Buy EUR 21,964.00
02.08.2023 Stiller, Dr. Olaf Supervisory board Buy EUR 9,670.30
02.08.2023 Stiller, Johanna Close relation Buy EUR 5,625.00

Capital Markets Information

ISIN

DE0006577109

LEI

3912008FCA63AGIMEV74

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.